Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Clinical trial NCT00871910 · COMPLETED

Trial details

NCT number: NCT00871910
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Lymphoma, Non-Hodgkin Multiple Myeloma

Start date: 2006-10-11
Primary completion: 2010-02-22
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.